Shane Ward - Mar 31, 2022 Form 4 Insider Report for Cidara Therapeutics, Inc. (CDTX)

Role: CHIEF LEGAL OFFICER
Signature: /s/ Shane Ward
Stock symbol: CDTX
Transactions as of: Mar 31, 2022
Transactions value $: -$19,191
Form type: 4
Date filed: 4/4/2022, 05:12 PM
Previous filing: Aug 27, 2021
Next filing: Mar 13, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	CDTX	Common Stock	Award	$0	+35K		$0.00	35K	Mar 31, 2022	Direct	F1
transaction	CDTX	Common Stock	Award	$0	+69K	+197.22%	$0.00	104K	Mar 31, 2022	Direct	F2
transaction	CDTX	Common Stock	Tax liability	-$19.2K	-23.1K	-22.23%	$0.83	80.9K	Mar 31, 2022	Direct	F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	CDTX	Employee Stock Option (right to buy)	Award	$0	+70K		$0.00	70K	Mar 31, 2022	Common Stock	70K	$0.83	Direct	F4

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents time-based Restricted Stock Units (RSUs) granted on March 31, 2022. All RSUs vest in three equal annual installments, with 1/3 vesting on each of March 10, 2023, 2024, and 2025, subject to continuous service through each such vesting date.
F2	Represents RSUs granted on March 31, 2022. All RSUs are fully vested as of the grant date.
F3	Shares withheld for taxes on RSU vesting.
F4	The option shall vest and become exercisable in a series of thirty-six (36) successive equal monthly installments measured from the Vesting Commencement Date of March 31, 2022.